share_log

Alimera Sciences Analyst Ratings

Alimera Sciences Analyst Ratings

Alimera Sciences分析師評級
Benzinga Analyst Ratings ·  2022/11/21 21:36
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/21/2022 6% Alliance Global Partners $11 → $4.5 Downgrades Buy → Neutral
07/28/2022 111.99% HC Wainwright & Co. $8 → $9 Maintains Buy
05/10/2022 88.44% HC Wainwright & Co. $10 → $8 Maintains Buy
02/25/2022 135.55% HC Wainwright & Co. $12 → $10 Maintains Buy
08/16/2021 182.66% HC Wainwright & Co. $16 → $12 Maintains Buy
04/15/2021 276.88% HC Wainwright & Co. $14 → $16 Maintains Buy
04/14/2020 229.77% HC Wainwright & Co. $15 → $14 Reiterates → Buy
04/07/2020 253.32% B. Riley Securities $24 → $15 Maintains Buy
11/18/2019 253.32% HC Wainwright & Co. $1 → $15 Maintains Buy
10/31/2019 -76.45% HC Wainwright & Co. $1.5 → $1 Maintains Buy
05/28/2019 -29.34% Craig-Hallum → $3 Initiates Coverage On → Buy
06/29/2018 -35.22% B. Riley Securities → $2.75 Initiates Coverage On → Buy
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
11/21/2022 6% 聯盟全球合作伙伴 $11 → $4.5 評級下調 購買→中性
07/28/2022 111.99% HC Wainwright公司 $8 → $9 維護
05/10/2022 88.44% HC Wainwright公司 $10 → $8 維護
02/25/2022 135.55% HC Wainwright公司 $12 → $10 維護
08/16/2021 182.66% HC Wainwright公司 $16 → $12 維護
04/15/2021 276.88% HC Wainwright公司 $14 → $16 維護
04/14/2020 229.77% HC Wainwright公司 $15 → $14 重申 →購買
04/07/2020 253.32% B.萊利證券 $24 → $15 維護
11/18/2019 253.32% HC Wainwright公司 $1 → $15 維護
10/31/2019 -76.45% HC Wainwright公司 $1.5 → $1 維護
05/28/2019 -29.34% 克雷格-哈勒姆 → $3 開始承保 →購買
06/29/2018 -35.22% B.萊利證券 → $2.75 開始承保 →購買

What is the target price for Alimera Sciences (ALIM)?

阿里梅拉科學公司(Alim)的目標價是多少?

The latest price target for Alimera Sciences (NASDAQ: ALIM) was reported by Alliance Global Partners on November 21, 2022. The analyst firm set a price target for $4.50 expecting ALIM to rise to within 12 months (a possible 6.00% upside). 4 analyst firms have reported ratings in the last year.

聯盟全球合作伙伴於2022年11月21日報道了阿里梅拉科學公司(納斯達克:ALIM)的最新目標價。這家分析公司將目標價定為4.50美元,預計Alim將在12個月內上漲(可能上漲6.00%)。去年有4家分析公司公佈了評級。

What is the most recent analyst rating for Alimera Sciences (ALIM)?

Alimera Sciences(Alim)的最新分析師評級是什麼?

The latest analyst rating for Alimera Sciences (NASDAQ: ALIM) was provided by Alliance Global Partners, and Alimera Sciences downgraded their neutral rating.

阿里梅拉科學公司(納斯達克股票代碼:ALIM)的最新分析師評級由聯盟全球合作伙伴提供,阿里梅拉科學公司下調了其中性評級。

When is the next analyst rating going to be posted or updated for Alimera Sciences (ALIM)?

Alimera Sciences(Alim)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alimera Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alimera Sciences was filed on November 21, 2022 so you should expect the next rating to be made available sometime around November 21, 2023.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閲公共財務報表,與Alimera Sciences的高管和客户交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Alimera Sciences的上一次評級是在2022年11月21日提交的,所以你應該預計下一次評級將在2023年11月21日左右提供。

Is the Analyst Rating Alimera Sciences (ALIM) correct?

分析師對Alimera Sciences(Alim)的評級正確嗎?

While ratings are subjective and will change, the latest Alimera Sciences (ALIM) rating was a downgraded with a price target of $11.00 to $4.50. The current price Alimera Sciences (ALIM) is trading at is $4.25, which is out of the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的Alimera Sciences(Alim)評級被下調,目標價為11.00美元至4.50美元。Alimera Sciences(Alim)目前的交易價格為4.25美元,超出了分析師的預測區間。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論